Consider a hypothetical partnership with all US companies, except one major, to distribute and sell our valve.
If the excluded company had an existing Market Capitalisation of around USD $55B, what do you think it would be worth to them, to buy us, alternatively consider what it would be worth to them, to ignore us.
Anteris may consider retaining manufacturing rights as a separate entity in another value-added spinoff.
There are obviously advantages and disadvantages, but it does provide our company with significant power and opportunities to set our own prices and terms, making us one of the most undervalued companies on the global market.
Food for thought
$66.32 price target - Evolution Capital initiation of coverage, page-46
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |